Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: The roles of glutamate, dopamine, acetylcholine and corticosteroids

Brain Research

Volumn 855, Issue 1, 2000, Pages 1-10

  Griffiths, M R ^a   Cooper, A J ^a   Barber, D J ^a   Mitchell, I J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Amphetamine; Apoptosis; Caudate; Corticosteroid; NMDA; PCP

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; CORTICOSTEROID; DIZOCILPINE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; MIFEPRISTONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG SCREENING; GLOBUS PALLIDUS; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACETYLCHOLINE; ADRENAL CORTEX HORMONES; AMPHETAMINE; ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLOBUS PALLIDUS; GLUTAMIC ACID; HORMONE ANTAGONISTS; MALE; MIFEPRISTONE; MUSCARINIC ANTAGONISTS; NEOSTRIATUM; NEURONS; PHENCYCLIDINE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE; STRESS;

EID: 0033955299     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01917-4     Document Type: Article

References (77)

1. Albin R.L., Reiner A., Anderson K.D., Penney J.B., Young A.B. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity akinesia. Ann. Neurol. 27:1990;357-365.
2. Beers M.H., Passman L.J. Antihypertensive medications and depression. Drugs. 40:1990;792-799.
3. Berretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68:1992;767-777.
4. Borowsky B., Kuhn C.M. D1-dopamine and D2-dopamine receptors stimulate hypothalamopituitary adrenal activity in rats. Neuropharmacology. 31:1992;671-678.
5. Ceci A., French E.D. Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex. Life Sci. 45:1989;637-646.
6. Charlett A., Dobbs R.J., Purkiss A.G., Wright D.J., Peterson D.W., Weller C., Dobbs S.M. Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol. Scand. 97:1998;77-85.
7. Cheng N., Maeda T., Kume T., Kaneko S., Kochiyama H., Akaike A., Goshima Y., Misu Y. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743:1996;278-283.
8. Cooper A.J., Fraser M., Foreshaw M., Barber D.J., Mitchell I.J. Acute administration of D1 dopamine agonists and a D2 antagonist induce apoptosis of a subpopulation of striatal neurons. Brain Res. Assoc. Abstr. 14:1997;58.
9. Cooper A.J., Moser B., Mitchell I.J. A subset of striatopallidal neurons are Fos-immunopositive following acute monoamine depletion in the rat. Neurosci. Lett. 187:1995;189-192.
10. Davison K., Bagley C.R. Schizophrenia-like psychoses associated with organic cerebral disorders - a review. Psychiatr. Dev. 1:1969;1-34.
11. Deupree D.L., Tang X.W., Yarom M., Dickman E., Kirch R.D., Schloss J.V., Wu J.Y. Studies of NMDA- and non-NMDA-mediated neurotoxicity in cultured neurons. Neurochem. Int. 29:1996;255-261.
12. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 13:1993;3847-3859.
13. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res. Rev. 19:1994;223-239.
14. Ellison G. The NMDA antagonists, phencyclidine, ketamine and dizocilpine, as both behavioural and anatomical models of dementias. Brain Res. Rev. 20:1995;250-267.
15. Ellison G., Switzer R.C. Dissimilar patterns of degeneration in brain following 4 different addictive stimulants. NeuroReport. 5:1993;17-20.
16. Farber N.B., Price M.T., Labruyere J., Nemnich J., St. Peter H., Wozniak D.F., Olney J.W. Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol. Psychiatry. 34:1993;119-121.
17. Fix A.S., Wozniak D.F., Truex L.L., McEwen L., Miller J.P., Olney J.W. Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate retrosplenial cortex. Brain Res. 696:1995;194-204.
18. Fugikawa D.G. Effects of N-methyl-D-aspartate-receptor blockade on high-potassium-induced neuronal death and glutamate release. Neurosci. Lett. 226:1997;25-28.
19. Gao X.M., Shirakawa O., Du F., Tamminga C.A. Delayed regional metabolic actions of phencyclidine. Eur. J. Pharmacol. 241:1993;7-15.
20. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
21. Gerfen C.R., Young W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
22. Giovannini M.G., Mutolo D., Bianchi L., Michelassi A., Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J. Neurosci. 14:1994;1358-1365.
23. Goebel S., Dietrich M., Jarry H., Wuttke W. Indirect evidence to suggest that prolactin mediates the adrenal action of haloperidol to stimulate aldosterone and corticosterone secretion in rats. Endocrinology. 130:1992;914-919.
24. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6912-6916.
25. Griffiths M.R., Cooper A.J., Mitchell I.J. Phencyclidine induces D1 dopamine receptor-mediated Fos-like immunoreactivity in discretely localised populations of striatopallidal and striatoentopeduncular neurons of the rat. Brain Res. 821:1999;177-189.
26. Haghighi S.S., Johnson G.C., de Vergel C.F., Vergel Rivas B.J. Pretreatment with NMDA receptor antagonist, MK801, improves neurophysiological outcome after an acute spinal cord injury. Neurol. Res. 18:1996;509-515.
27. Handa R.J., Nunley K.M., Bollnow M.R. Induction of c-fos mRNA in the brain and anterior pituitary gland by a novel environment. NeuroReport. 4:1993;1079-1082.
28. Harrow M., Yonan C.A., Sands J.R., Marengo J. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophr. Bull. 20:1994;327-338.
29. Hashimoto K., Tomitaka S., Narita N., Minabe Y., Iyo M., Fukui S. Induction of heat shock protein (HSP)-70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of protective effects of sigma receptor ligands. Addict. Biol. 1:1996;61-70.
30. Hassan A.H.S., VonRosenstiel P., Patchev V.K., Holsboer F., Almeida O.F.X. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp. Neurol. 140:1996;43-52.
31. Hedreen J.C., Folstein S.E. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54:1995;105-120.
32. Hermenegildo C., Marcaida G., Montoliu C., Grisolia S., Minana M.D., Felipo V. NMDA receptor antagonists prevent acute ammonia toxicity in mice. Neurochem. Res. 21:1996;1237-1244.
33. Hertel P., Mathe J.M., Nomikos G.G., Iurlo M., Mathe A.A., Svensson T.H. Effects of D-amphetamine and phencyclidine on behaviour and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res. 72:1995;103-114.
34. Ikeda J., Terakawa S., Murota S., Morita I., Hirakawa K. Nuclear disintegration as a leading step of glutamate excitotoxicity in brain neurons. J. Neurosci. Res. 43:1996;613-622.
35. Ikemoto S., Goeders N.E. Microinjections of dopamine agonists and cocaine elevate plasma corticosterone: dissociation effects among the ventral and dorsal striatum and medial prefrontal cortex. Brain Res. 814:1998;171-178.
36. Ismail K., Wessely S. Psychiatric complications of corticosteroid therapy. Br. J. Hosp. Med. 53:1995;495-499.
37. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
38. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurons: chemical, physiological and morphological characterization. TINS. 18:1995;527-535.
39. Kelley A.E., Delfs J.M., Chu B. Neurotoxicity induced by the D1 agonist, SKF38393, following microinjection into rat brain. Brain Res. 532:1990;342-346.
40. Kiraly S.J., Ancill R.J., Dimitrova G. The relationship of endogenous cortisol to psychiatric disorder: a review. Can. J. Psychiatry. 42:1997;415-420.
41. Le Moine C., Svenningsson P., Fredholm B., Bloch B. Dopamine-adenosine interactions in the striatum and globus pallidus: inhibition of striatopallidal neurons through either D2 or A2a receptors enhances D1 receptor-mediated effects on c-fos expression. J. Neurosci. 17:1997;8038-8048.
42. Lillrank S.M., O'Connor W.T., Saransaari P., Ungerstedt U. In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized rats. Acta Physiol. Scand. 150:1994;109-115.
43. Liste I., Guerra M.J., Caruncho H.J., Labandeira-Garcia J.L. Treadmill running induces striatal Fos expression via NMDA glutamate and dopamine receptors. Exp. Brain Res. 115:1997;458-469.
44. Mann J.J., Kapur S. A dopaminergic hypothesis of major depression. Clin. Neuropharmacol. 18:1995;S57-S65.
45. Mendez M.F. Huntington's disease - update and review of neuropsychiatric aspects. Int. J. Psychiatry Med. 24:1994;189-208.
46. Mitchell I.J., Cooper A.C., Griffiths M.R., Barber D.J. Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis? Neuroscience. 84:1998;489-501.
47. Mitchell I.J., Lawson S., Moser B., Laidlaw S.M., Cooper A.J., Walkinshaw G., Waters C.M. Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat. Neuroscience. 63:1994;1-5.
48. Näkki R., Sharp F.R., Sagar S.M. FOS expression in the brainstem and cerebellum following phencyclidine and MK-801. J. Neurosci. Res. 43:1996;203-212.
49. Näkki R., Sharp F.R., Sagar S.M., Honkaniemi J. Effects of phencyclidine on immediate early gene expression in the brain. J. Neurosci. Res. 45:1996;13-27.
50. Offen D., Ziv I., Sternin H., Melamed E., Hochman A. Prevention of dopamine induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp. Neurol. 141:1996;32-39.
51. Olney J.W., Farber N.B. Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. J. Clin. Psychiatry. 55:1994;43-46.
52. Olney J.W., Farber N.B. Response to commentaries and to the challenge of building a perfect theory to explain schizophrenia. Arch. Gen. Psychiatry. 52:1995;1019-1024.
53. Olney J.W., Farber N.B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology. 113:1995;335-345.
54. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
55. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 254:1991;1515-1518.
56. Olney J.W., Price M.T., Fuller T.A., Labruyere J., Sampson L., Carpenter M., Mahan K. The anti-excitotoxic effects of certain anesthetics, analgesics and sedative hypnotics. Neurosci. Lett. 68:1986;29-34.
57. Olney J.W., Price M.T., Salles S., Labruyere J., Friedich G. MK-801 powerfully protects against N-methyl-aspartate neurotoxicity. Eur. J. Pharmacol. 141:1987;357-361.
58. Overton P.G., Tong Z.Y., Brain P.F., Clark D. Preferential occupation of mineralocorticoid receptors by corticosterone enhances glutamate-induced burst firing in rat midbrain dopaminergic neurons. Brain Res. 737:1996;146-154.
59. Pauly J.R., Robinson S.F., Collins A.C. Chronic corticosterone administration enhances behavioural sensitization to amphetamine in mice. Brain Res. 620:1993;195-202.
60. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Harcourt Brace Jovanovich, 1982.
61. Piazza P.V., Le Moal N. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Rev. 25:1997;359-372.
62. Piazza P.V., RougePont F., Deroche V., Maccari S., Simon S., Le Moal M. Glucocorticoids have state dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8716-8720.
63. Reagen L.P., McEwen B.S. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J. Chem. Neuroanat. 13:1997;149-167.
64. Seckl J.R. 11β-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Front. Neuroendocrinol. 18:1997;49-99.
65. Sharp F.R., Butman M., Koistinaho J., Aardalen K., Näkki R., Massa S.M. Phencyclidine induction of the hsp-70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage-gated calcium channels. Neuroscience. 62:1994;1079-1092.
66. Sharp J.W. Phencyclidine (PCP) acts at σ sites to induce c-fos gene expression. Brain Res. 758:1997;51-58.
67. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G.C., Schilling K., Robertson L.M., Curran T., Morgan J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363:1993;166-169.
68. Strakowski S.M., DelBello M.P., Sax K.W., Zimmerman M.E., Shear P.K., Hawkins J.M., Larson E.R. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch. Gen. Psychiatry. 56:1999;254-260.
69. Su T.P., London E.D., Jaffe J.H. Steroid binding at sigma-receptors suggests a link between endocrine, nervous, and immune systems. Science. 240:1988;219-221.
70. Vickroy T.W., Johnson K.M. Similar dopamine-releasing effects of phencyclidine and non-amphetamine stimulants in striatal slices. J. Pharmacol. Exp. Ther. 223:1982;669-674.
71. 3H ]BTCP): a new phencyclidine analogue selective for the dopamine uptake complex Eur. J. Pharmacol. 148:1988;427-436.
72. Walkinshaw G., Waters C.M. Induction of apoptosis in catecholaminergic PC-12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest. 95:1995;2458-2464.
73. Ward D., Trevor A. Phencyclidine-induced alterations in rat muscarinic cholinergic receptor regulation. Eur. J. Pharmacol. 74:1981;189-193.
74. Waters C.M., Moser W., Walkinshaw G., Mitchell I.J. Death of neurons in the neonatal rodent and primate globus pallidus occurs by a mechanism of apoptosis. Neuroscience. 63:1994;881-894.
75. Wirtshafter D., Asin K.E. Interactive effects of stimulation of D1 and D2 dopamine-receptors on fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35:1994;85-91.
76. Wirtshafter D., Schardt G., Asin K.E. Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats. Brain Res. 771:1997;271-277.
77. Woolley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531:1990;225-231.